000999.SZ
Strong BuyUnloved QualityChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. · Healthcare · China · $5.8B
CNY 24.19 +3.2% · close 30 Sep · scored 3 Oct
Unloved Quality: Strong and cheap; the market has not turned yet.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
Read
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. manufactures and markets over-the-counter (OTC) drugs and Traditional Chinese Medicine (TCM) prescription products. The company commands the leading position in China's OTC market, anchored by the highly recognized '999' brand. It is a consumer healthcare powerhouse with unmatched brand equity and an extensive retail pharmacy distribution network.
FINANCIAL SUMMARY (CNY)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.1B | 24.7B | 27.6B | 31.6B | 20.5% | 31.8B | 33.3B | 35.6B | 6.1% |
| EPS (CNY) | 1.47 | 1.72 | 2.02 | 2.06 | 12.0% | 1.97 | 2.41 | 2.65 | 13.5% |
| Shares | 1.7B | 1.7B | 1.7B | 1.7B | -0.4% | 1.7B | — | — | — |
| Debt | 391.1M | 3.0B | 1.3B | 6.5B | 154.6% | 4.5B | — | — | — |
| Equity | 17.0B | 19.0B | 19.9B | 22.2B | 9.2% | — | — | — | — |
| Op CF | 3.0B | 4.2B | 4.4B | 5.5B | 22.4% | 5.1B | — | — | — |
| Inv CF | -2.5B | -793.5M | -1.1B | -7.4B | — | — | — | — | — |
| Fin CF | -575.5M | 450.4M | -4.6B | 1.6B | — | — | — | — | — |
Calmer than 89% of stocks we rank over the past year (21% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000999.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000999.SZ | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.(you) | $5.8B | 92 | Strong Buy |
| 002603.SZ | Shijiazhuang Yiling Pharmaceutical Co., Ltd. | $3.8B | 92 | Strong Buy |
| 000423.SZ | Dong-E-E-Jiao Co., Ltd. | $4.3B | 95 | Strong Buy |
| 000963.SZ | Huadong Medicine Co., Ltd | $6.8B | 85 | Strong Buy |
| 000513.SZ | Livzon Pharmaceutical Group Inc. | $3.6B | 90 | Strong Buy |
| 2096.HK | Simcere Pharmaceutical Group Limited | $3.7B | 96 | Strong Buy |
| 002001.SZ | Zhejiang NHU Company Ltd. | $11.8B | 92 | Strong Buy |
| 600566.SS | Hubei Jumpcan Pharmaceutical Co., Ltd. | $3.4B | 96 | Strong Buy |
| 600535.SS | Tasly Pharmaceutical Group Co., Ltd | $3.0B | 96 | Strong Buy |
| 600380.SS | Joincare Pharmaceutical Group Industry Co.,Ltd. | $2.5B | 91 | Strong Buy |
Peer medians: ROE 4.3% · P/E 27.8x · Gross margin 52.7%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.